Merck & Co., Inc. (MRK) - Stock Analysis

Merck & Co., Inc. Financial Analysis

Current Price: $114.80 -0.73%

Market Cap: $283.54B

Sector: Healthcare

P/E Ratio: 14.43

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuti

Report Contents

  • Income Statement Analysis (5-year history)
  • Balance Sheet Overview
  • Cash Flow Statement
  • Key Financial Ratios
  • Valuation Metrics (P/E, EV/EBITDA, P/S)
  • Peer Comparison
  • Revenue & Earnings Growth Trends
  • Margin Analysis
  • Analyst Price Targets
  • DCF Valuation Model